GlassScriptPhysician profile
Eric C Leuthardt
NPI 1265465132
$78,489.94
in general payments reported to CMS, 2019-2025
8 companies · $68K in 2025
The $68K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,970 · 2020: $125 · 2021: $297 · 2022: $5,897 · 2023: $75.97 · 2024: $375 · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Food and Beverage: $75.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $68,125.00 |
| Food and Beverage | $75.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurolutions, INC. | $65,000.00 | 2025 | Neurolutions Ipsihand Upper Extremity Rehabilitation System |
| Monteris Medical Corporation | $6,952.37 | 2019-2025 | Neuroblate |
| Medtronic, INC. | $5,813.65 | 2022 | |
| Stryker Corporation | $676.99 | 2019 | |
| Imperative Care, INC | $46.93 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$25,231.25 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Leuthardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.